(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-25 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1475490
| Date | Daily Closing Price | Open | High | Low | Volume |
| 25 Tue Jun 2024 | 0.87 | 0.89 | 0.89 | 0.86 | 0.525 times |
| 24 Mon Jun 2024 | 0.88 | 0.89 | 0.92 | 0.88 | 0.512 times |
| 21 Fri Jun 2024 | 0.89 | 0.87 | 0.90 | 0.86 | 0.399 times |
| 20 Thu Jun 2024 | 0.87 | 0.87 | 0.90 | 0.86 | 1.263 times |
| 18 Tue Jun 2024 | 0.88 | 0.93 | 0.94 | 0.85 | 1.896 times |
| 18 Tue Jun 2024 | 0.88 | 0.93 | 0.94 | 0.85 | 1.896 times |
| 17 Mon Jun 2024 | 0.94 | 1.01 | 1.02 | 0.92 | 1.351 times |
| 14 Fri Jun 2024 | 1.01 | 1.02 | 1.04 | 1.00 | 0.565 times |
| 13 Thu Jun 2024 | 1.04 | 1.05 | 1.05 | 1.02 | 0.407 times |
| 12 Wed Jun 2024 | 1.04 | 1.05 | 1.08 | 1.03 | 0.598 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 0.9, but if it comes above 0.9, then a intra day buy could be more profitable.
If you take a sell trade below 0.9, then use 0.9 as stoploss and 0.8 as target. However if you take a buy trade in stock , then use 0.9 as stoploss and 0.99 as target.
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.85 |
| Upside Target | 0.92 |
| Upside Target | 0.94 |
| Upside Target | 0.96 |
| Upside Target | 1.00 |
| Upside Target | 1.02 |
| Upside Target | 1.08 |
| Upside Target | 1.15 |
| Upside Target | 1.24 |
| Upside Target | 1.34 |
| Upside Target | 1.55 |
| Upside Target | 1.79 |
| Upside Target | 2.05 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 0.85 |
| Downside Intraday Target | 0.82 |
| Upside Intraday Target | 0.91 |
| Upside Intraday Target | 0.94 |
| Upside Intraday Target | 0.88 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 25 Tue Jun 2024 | 0.87 | 0.89 | 0.92 | 0.86 | 0.291 times |
| 21 Fri Jun 2024 | 0.89 | 0.93 | 0.94 | 0.85 | 1.096 times |
| 18 Tue Jun 2024 | 0.88 | 1.01 | 1.02 | 0.85 | 0.858 times |
| 14 Fri Jun 2024 | 1.01 | 1.01 | 1.08 | 1.00 | 0.508 times |
| 07 Fri Jun 2024 | 1.02 | 1.10 | 1.15 | 0.96 | 0.53 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 25 Tue Jun 2024 | 0.87 | 1.10 | 1.15 | 0.85 | 0.784 times |
| 31 Fri May 2024 | 1.13 | 1.19 | 1.34 | 1.00 | 1.279 times |
| 30 Tue Apr 2024 | 1.19 | 1.55 | 1.55 | 0.87 | 0.71 times |
| 28 Thu Mar 2024 | 1.58 | 1.56 | 2.05 | 1.24 | 1.055 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.91 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.91 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.